用于急性髓性白血病免疫治疗的CAR-NK细胞:过去,现在和未来
Leisheng Zhang1,2,3,4, Yuan Meng5, Hao Yao6
1Department of General Practice, Affiliated Hospital of Xiangnan University Chenzhou 423099, Hunan, China.
American journal of cancer research
|December 7, 2023
概括
化学抗原受体转化NK (CAR-NK) 细胞在治疗急性髓性白血病 (AML) 中表现有前途,为CAR-T细胞提供了潜在的替代方案,并解决了针对复发性和耐药性AML的当前疗法的局限性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 由于高死亡率,复发和抗化疗性,急性髓性白血病 (AML) 存在重大挑战.
- 目前的治疗方法,如全源造血干细胞移植 (allo-HSCT) 和CAR-T细胞有局限性,包括移植对宿主疾病和匹配限制.
研究的目的:
- 审查针对AML的CAR-NK细胞疗法的最新进展.
- 探索用于AML治疗的替代细胞来源,治疗点和CAR修饰策略.
主要方法:
- 对血液恶性瘤的CAR-NK细胞疗法的当前文献的综述.
- 对CAR-NK细胞优势的分析与现有的AML治疗相比.
- 讨论CAR-NK细胞发展的挑战和未来方向.
主要成果:
- 对于AML治疗,CAR-NK细胞提供了增强的特异性和细胞毒性.
- 它们提供了一种"现成"的全基因选择,绕过了敏感化要求.
- CAR-NK细胞为克服当前耐药性和复发性AML疗法的局限性提供了一个有希望的途径.
结论:
- CAR-NK细胞疗法是一种正在发展中的策略,有可能改善AML患者的治疗结果.
- 对细胞来源,点和传递的进一步研究对于临床转化至关重要.
- CAR-NK细胞可能通过利用CAR依赖性和NK细胞受体依赖性途径为AML提供一种新的治疗范式.
更多相关视频
11:02Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
5.6K
08:29Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Published on: October 4, 2024
824
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:27Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923